亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Current status of blood component therapy in surgical critical care

医学 重症监护医学 促红细胞生成素 贫血 输血 败血症 临床试验 血液管理 随机对照试验 外科 内科学
作者
Lena M. Napolitano
出处
期刊:Current Opinion in Critical Care [Lippincott Williams & Wilkins]
卷期号:10 (5): 311-317 被引量:35
标识
DOI:10.1097/01.ccx.0000140948.98019.8a
摘要

The use of blood component therapy, with transfusion of red cells, plasma, and platelets, is common in critical care. New evidence has emerged documenting the risks associated and lack of efficacy or improvement in clinical outcome with blood transfusion for the treatment of anemia in critically ill patients who are hemodynamically stable.The safety of a restrictive transfusion strategy (transfuse only if hemoglobin < 7 g/dL) was reported in 1999. Despite compelling evidence from this prospective randomized clinical trial, clinicians have not substantially changed practice regarding blood transfusion in critical care. The recently published CRIT trial reported that the mean pre-transfusion hemoglobin was 8.6 g/dL in this large multicenter trial that examined transfusion practices in critical care in the US. Furthermore, only 19% of hospitals had an institutional blood transfusion protocol. The Surviving Sepsis Campaign guidelines have also recommended blood transfusion only when hemoglobin falls to 7.0 g/dL, following resolution of tissue hypoperfusion and in the absence of significant coronary artery disease or acute hemorrhage. We have an increased understanding of the pathophysiology of the anemia associated with critical care, related to the inflammatory response, downregulation of erythropoietin, and lack of iron availability due to macrophage sequestration. Clinical trials are underway to confirm the efficacy of recombinant erythropoietin in the treatment of critically ill patients with anemia.Current data regarding blood transfusion thresholds and risks of blood transfusion have not as yet significantly altered practice patterns. Efforts to reduce blood transfusion rates in critically ill patients are required. These strategies will require education, unit and institutional protocols, and reduction of phlebotomy for diagnostic laboratory testing in the intensive care unit. Further investigations regarding anemia in critical care and new treatment and prevention strategies are required.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
我是老大应助胖墩儿驾到采纳,获得10
2秒前
5秒前
知足发布了新的文献求助10
11秒前
14秒前
17秒前
lzl008完成签到 ,获得积分10
20秒前
紫翼应助科研通管家采纳,获得10
30秒前
烟花应助科研通管家采纳,获得10
30秒前
科研通AI2S应助科研通管家采纳,获得10
31秒前
李健应助科研通管家采纳,获得10
31秒前
32秒前
32秒前
谢123完成签到 ,获得积分10
36秒前
汉堡包应助bai采纳,获得10
36秒前
lzl007完成签到 ,获得积分10
42秒前
49秒前
52秒前
53秒前
55秒前
testmanfuxk完成签到,获得积分10
56秒前
bai发布了新的文献求助10
58秒前
andrele发布了新的文献求助100
1分钟前
1分钟前
1分钟前
完美世界应助含蓄的荔枝采纳,获得10
1分钟前
alicr关注了科研通微信公众号
1分钟前
1分钟前
潇洒的奇异果完成签到,获得积分10
1分钟前
1分钟前
alicr发布了新的文献求助10
1分钟前
1分钟前
YifanWang应助Tyj采纳,获得30
1分钟前
李在猛完成签到 ,获得积分10
2分钟前
caca完成签到,获得积分0
2分钟前
2分钟前
bai完成签到 ,获得积分10
2分钟前
Tyj发布了新的文献求助10
2分钟前
桐桐应助科研通管家采纳,获得10
2分钟前
科研通AI2S应助科研通管家采纳,获得10
2分钟前
科研通AI5应助含蓄的荔枝采纳,获得10
2分钟前
高分求助中
Technologies supporting mass customization of apparel: A pilot project 600
Izeltabart tapatansine - AdisInsight 500
Chinesen in Europa – Europäer in China: Journalisten, Spione, Studenten 500
Arthur Ewert: A Life for the Comintern 500
China's Relations With Japan 1945-83: The Role of Liao Chengzhi // Kurt Werner Radtke 500
Two Years in Peking 1965-1966: Book 1: Living and Teaching in Mao's China // Reginald Hunt 500
Epigenetic Drug Discovery 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3815770
求助须知:如何正确求助?哪些是违规求助? 3359317
关于积分的说明 10402144
捐赠科研通 3077173
什么是DOI,文献DOI怎么找? 1690198
邀请新用户注册赠送积分活动 813659
科研通“疑难数据库(出版商)”最低求助积分说明 767713